LRMR
Price
$3.99
Change
+$0.01 (+0.25%)
Updated
Dec 20, 04:59 PM (EDT)
81 days until earnings call
PLRX
Price
$13.22
Change
-$0.08 (-0.60%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
Ad is loading...

LRMR vs PLRX

Header iconLRMR vs PLRX Comparison
Open Charts LRMR vs PLRXBanner chart's image
Larimar Therapeutics
Price$3.99
Change+$0.01 (+0.25%)
Volume$11.65K
CapitalizationN/A
Pliant Therapeutics
Price$13.22
Change-$0.08 (-0.60%)
Volume$82.26K
CapitalizationN/A
LRMR vs PLRX Comparison Chart
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. PLRX commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and PLRX is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (LRMR: $4.03 vs. PLRX: $13.22)
Brand notoriety: LRMR and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 125% vs. PLRX: 357%
Market capitalization -- LRMR: $256.82M vs. PLRX: $804.48M
LRMR [@Biotechnology] is valued at $256.82M. PLRX’s [@Biotechnology] market capitalization is $804.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, LRMR is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • LRMR’s TA Score: 4 bullish, 6 bearish.
  • PLRX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than PLRX.

Price Growth

LRMR (@Biotechnology) experienced а -34.76% price change this week, while PLRX (@Biotechnology) price change was -0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

LRMR is expected to report earnings on Mar 12, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($804M) has a higher market cap than LRMR($257M). LRMR YTD gains are higher at: -11.538 vs. PLRX (-27.002). LRMR has higher annual earnings (EBITDA): -73.44M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. LRMR (204M). LRMR has less debt than PLRX: LRMR (5.36M) vs PLRX (60.2M). LRMR (0) and PLRX (0) have equivalent revenues.
LRMRPLRXLRMR / PLRX
Capitalization257M804M32%
EBITDA-73.44M-197.04M37%
Gain YTD-11.538-27.00243%
P/E RatioN/AN/A-
Revenue00-
Total Cash204M405M50%
Total Debt5.36M60.2M9%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LRMRPLRX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 4 days ago
71%
View a ticker or compare two or three
Ad is loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHSX37.120.36
+0.98%
Artisan Small Cap Institutional
DFALX26.560.01
+0.04%
DFA Large Cap International I
SLLAX12.70N/A
N/A
SEI Small Cap F (SIMT)
VCKSX10.86N/A
N/A
Virtus KAR Small-Mid Cap Growth C
CIGYX10.38-0.05
-0.48%
AB Concentrated International Growth Adv

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+1.13%
SVRA - LRMR
39%
Loosely correlated
+0.31%
ABSI - LRMR
36%
Loosely correlated
+1.88%
IDYA - LRMR
36%
Loosely correlated
+3.31%
TRDA - LRMR
35%
Loosely correlated
+1.85%
BDTX - LRMR
35%
Loosely correlated
+1.60%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-0.60%
NTLA - PLRX
52%
Loosely correlated
+1.08%
BEAM - PLRX
50%
Loosely correlated
+8.16%
RCKT - PLRX
50%
Loosely correlated
+2.03%
CRSP - PLRX
50%
Loosely correlated
+0.83%
ETNB - PLRX
49%
Loosely correlated
+12.80%
More